The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(1H-pyrazol-3-yl)phenyl)-4-(dimethylamino)-1-(6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]indol-4-yl)piperidine-4-carboxamide ID: ALA3798270
PubChem CID: 127045879
Max Phase: Preclinical
Molecular Formula: C27H32N8O
Molecular Weight: 484.61
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)C1(C(=O)Nc2cccc(-c3cc[nH]n3)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1
Standard InChI: InChI=1S/C27H32N8O/c1-34(2)27(26(36)31-19-7-5-6-18(16-19)21-10-13-30-33-21)11-14-35(15-12-27)25-23-20-8-3-4-9-22(20)32-24(23)28-17-29-25/h5-7,10,13,16-17H,3-4,8-9,11-12,14-15H2,1-2H3,(H,30,33)(H,31,36)(H,28,29,32)
Standard InChI Key: PAOKFNVXQHEMAT-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 41 0 0 0 0 0 0 0 0999 V2000
-3.7006 0.8244 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.7006 -0.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4915 -1.3190 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4915 1.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2274 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2274 -0.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.3190 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5059 3.0395 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8107 3.7796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8223 5.2795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5291 6.0395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2243 5.2996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2127 3.7996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8347 6.7382 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2347 6.7580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2441 7.9579 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0712 6.0182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3652 6.7784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6714 6.0409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9633 6.8032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9489 8.3032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6428 9.0407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3510 8.2783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2274 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2274 -0.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4732 -1.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7372 -0.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7372 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4732 1.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8449 7.9382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8690 6.1298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2701 6.0653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4244 4.5861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8950 4.2906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6305 5.5979 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6145 6.7013 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 25 1 0
24 5 1 0
4 8 1 0
8 9 1 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
11 14 1 0
11 15 1 0
15 16 2 0
15 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
24 25 2 0
24 29 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
14 30 1 0
14 31 1 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 1 0
36 32 2 0
20 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 484.61Molecular Weight (Monoisotopic): 484.2699AlogP: 3.77#Rotatable Bonds: 5Polar Surface Area: 105.83Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.99CX Basic pKa: 7.82CX LogP: 3.94CX LogD: 3.36Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.40Np Likeness Score: -1.47
References 1. Alen J, Bourin A, Boland S, Geraets J, Schroeders P, Defert O. (2016) Tetrahydro-pyrimido-indoles as selective LIMK inhibitors: synthesis, selectivity profiling and structureactivity studies, 7 (3): [10.1039/C5MD00473J ]